BSE filing, NSE: JSFB. Summary written from the filing by ALFA Finder's alert engine.
Jana Small Finance Bank Ltd: key numbers
- Share price
- ₹378.75
- Market cap
- ₹4,009 Cr
- Revenue (annual)
- ₹5,353 Cr
- Net profit (annual)
- ₹326.4 Cr
- P/E (TTM)
- 8.4×Sector 19.7×
- Promoter holding
- 16.87%-0.07% QoQ
- FII holding
- 5.10%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Jana Small Finance Bank Ltd
All →Jana Small Finance Bank Management Change
Jana Small Finance Bank appointed Ms. Sneha Sharma as Company Secretary & Compliance Officer, effective November 1, 2026. The role is designated as a Key Managerial Personnel position.
Jana Small Finance Bank Earnings Call Transcript: Key Takeaways
Jana delivered its highest-ever quarterly profit before tax, reaching H1 profit parity with full-year FY26 results.
- Call
- Guides 100% growth
Jana Small Finance Bank Other Announcement
Jana Small Finance Bank filed a Regulation 54 security cover certificate for September 2026. It reports no secured debt, so no cover ratio applies.
Jana Small Finance Bank Investor Presentation: Key Takeaways
Q2 FY27 PAT Rs170 Cr (+127% YoY, +10% QoQ); NII Rs819 Cr (+35% YoY); NIM 7.54%. FY27 PAT growth guidance raised to ~100%.
- Call
- Guides 100% growth
Jana Small Finance Bank Employee Stock Options
Jana Small Finance Bank allotted 17,869 ESOP/RSU shares to employees. Paid-up capital increased marginally to 10.58 crore shares.
Jana Small Finance Bank Q2 FY27 Results: Net Profit ₹170 Cr, Up 126.7% YoY
Jana Small Finance Bank Ltd reported revenue from operations of ₹1,587 Cr (+22.6% YoY) and net profit of ₹170 Cr (+126.7% YoY) for Q2 FY27.
- Key figure
- Net profit ₹170 Cr · +126.7% YoY
Other board meeting date announcements
All →Patel Engineering Board Meeting Date
Patel Engineering has scheduled its Board meeting for November 5, 2026, to approve Q1 and H1 FY27 unaudited results. No financial figures or decisions are reported in this advance notice.
GKB Ophthalmics Board Meeting Date
GKB Ophthalmics scheduled its Board Meeting for November 12, 2026. The meeting will consider approving unaudited results for the September 30, 2026 quarter and half year.
Bombay Oxygen Investments Board Meeting Date
Board meeting scheduled for Nov 6, 2026 to approve Q1 and H1 FY27 unaudited results. Trading window closed for insiders Oct 1–Nov 8, 2026.
OCCL Board Meeting Date
OCCL Ltd has scheduled its Board meeting for 6 November 2026 to consider Q1 FY27 unaudited results and a possible interim dividend. The trading window for designated persons closed from 1 October 2026.
TCM Board Meeting Date
TCM Limited intimated a Board meeting for 06/11/2026 to approve Q2 FY27 results. The trading window will reopen 48 hours after the results declaration.
Mercury Laboratories Board Meeting Date
Mercury Laboratories scheduled its Board meeting for November 5, 2026, to approve Q2/H1 FY27 results. Trading window remains closed until 48 hours post-announcement.